C Dobrinja1, P Makovac2, M Pastoricchio3, T Cipolat Mis4, S Bernardi5, B Fabris6, L Piscopello7, N de Manzini8. 1. Division of General Surgery, Department of Medical and Surgical Sciences, Hospital of Cattinara, University of Trieste, Italy. Electronic address: ch_dobrinja@yahoo.it. 2. Division of General Surgery, Department of Medical and Surgical Sciences, Hospital of Cattinara, University of Trieste, Italy. 3. Division of General Surgery, Department of Medical and Surgical Sciences, Hospital of Cattinara, University of Trieste, Italy. Electronic address: manuela.pastoricchio@gmail.com. 4. Division of General Surgery, Department of Medical and Surgical Sciences, Hospital of Cattinara, University of Trieste, Italy. Electronic address: tommy86_b@icloud.com. 5. Division of Clinical Medicine, Hospital of Cattinara, University of Trieste, Italy. Electronic address: stella.bernardi@aots.sanita.fvg.it. 6. Division of Clinical Medicine, Hospital of Cattinara, University of Trieste, Italy. Electronic address: bruno.fabris@aots.sanita.fvg.it. 7. Division of Endocrinology, Maggiore Hospital, Trieste, Italy. Electronic address: lanfranco.piscopello@aots.sanita.fvg.it. 8. Division of General Surgery, Department of Medical and Surgical Sciences, Hospital of Cattinara, University of Trieste, Italy. Electronic address: demanzini@units.it.
Abstract
BACKGROUND: The association between chronic lymphocytic thyroiditis (CLT) and papillary thyroid carcinoma (PTC) has been investigated for several years from different perspectives. In spite of that, there were only few attempts to design a common frame of references to understand the complex mutual interactions between the various pathways of inflammatory response and of thyroid tumor induction and progression. This study compares two independent groups of patients aiming to determine the frequency and the prognostic significance of CLT in patients with PTC. MATERIAL AND METHODS: From January 2005 to September 2013, we conducted a retrospective study on 160 patients with PTC who underwent thyroidectomy. CLT was diagnosed histopathologically. Age, sex, tumor features (dimensions, angioinvasion, capsular infiltration, mono/multifocality and lymph node metastases) pathologic findings and outcome were considered. Mean follow-up (metastasis, completeness-of-resection, serum thyroglobulin levels, tumor recurrence) period was 61 months (ranged from 18 to 132 months). A p < 0.05 was considered statistically significant. RESULTS: Patients were divided in 2 groups. In group A there were 90 patients affected by PTC alone, and in group B there were 70 patients affected with PTC associated with CLT. Our data showed that the presence of CLT correlate with a lower grade of PTC (p < 0.05). Considering the sex of the patients there were a statistically significant correlation (p < 0.02) and the presence of CLT associated with PTC was most representative in female patients. CONCLUSIONS: The presence of CLT in patients with PTC correlated with a lower grade of PTC, but it does not affect the overall survival of papillary thyroid cancers.
BACKGROUND: The association between chronic lymphocytic thyroiditis (CLT) and papillary thyroid carcinoma (PTC) has been investigated for several years from different perspectives. In spite of that, there were only few attempts to design a common frame of references to understand the complex mutual interactions between the various pathways of inflammatory response and of thyroid tumor induction and progression. This study compares two independent groups of patients aiming to determine the frequency and the prognostic significance of CLT in patients with PTC. MATERIAL AND METHODS: From January 2005 to September 2013, we conducted a retrospective study on 160 patients with PTC who underwent thyroidectomy. CLT was diagnosed histopathologically. Age, sex, tumor features (dimensions, angioinvasion, capsular infiltration, mono/multifocality and lymph node metastases) pathologic findings and outcome were considered. Mean follow-up (metastasis, completeness-of-resection, serum thyroglobulin levels, tumor recurrence) period was 61 months (ranged from 18 to 132 months). A p < 0.05 was considered statistically significant. RESULTS:Patients were divided in 2 groups. In group A there were 90 patients affected by PTC alone, and in group B there were 70 patients affected with PTC associated with CLT. Our data showed that the presence of CLT correlate with a lower grade of PTC (p < 0.05). Considering the sex of the patients there were a statistically significant correlation (p < 0.02) and the presence of CLT associated with PTC was most representative in female patients. CONCLUSIONS: The presence of CLT in patients with PTC correlated with a lower grade of PTC, but it does not affect the overall survival of papillary thyroid cancers.
Authors: Marina Carvalho S Côrtes; Pedro Weslley Rosario; Gabriela Franco Mourão; Maria Regina Calsolari Journal: Braz J Otorhinolaryngol Date: 2017-06-02